Leukapheresis Market, by Device Type (Apheresis Devices, Leukapheresis Columns & Cell Separators, Leukoreduction Filters, and Leukapheresis Disposables), By Application (Research Applications and Therapeutic Applications), by End User (Hospitals, Academic

Leukapheresis Market, by Device Type (Apheresis Devices, Leukapheresis Columns & Cell Separators, Leukoreduction Filters, and Leukapheresis Disposables), By Application (Research Applications and Therapeutic Applications), by End User (Hospitals, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Blood Component Providers and Blood Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Leukapheresis is a process, in which white blood cells are separated from a sample of blood. It is a specific type of apheresis used for separating a particular constituent of blood and returning the remaining part to the circulation. Leukapheresis is distinctly different from plasmapheresis and red cell exchange procedures.
Market Dynamics
The global leukapheresis devices market is expected to witness significant growth during the forecast period, owing to increasing prevalence of leukemia. For instance, according to the National Cancer Institute, in 2017, there were an estimated 434,982 people living with leukemia in the U.S. and according to the same source, the number of new cases of leukemia increased on an average rate of 0.3% each year over the last 10 years (from 2006 to 2015).
Key features of the study:
This report provides in-depth analysis of the global leukapheresis devices market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global leukapheresis devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, BioIVT, Grifols, S.A, and Key Biologics, LLC
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
The global leukapheresis devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for leukapheresis devices market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Leukapheresis Devices Market, By Device Type:
Apheresis Devices
Leukapheresis Columns & Cell Separators
Leukoreduction Filters
Leukapheresis Disposables
Global Leukapheresis Devices Market, By Application:
Research Applications
Therapeutic Applications
Global Leukapheresis Devices Market, By End User:
Hospitals
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Blood Component Providers and Blood Centers
Global Leukapheresis Devices Market, By Region:
North America
By Country:
U.S.
Canada
By Device Type:
Apheresis Devices
Leukapheresis Columns & Cell Separators
Leukoreduction Filters
Leukapheresis Disposables
By Application:
Research Applications
Therapeutic Applications
By End User:
Hospitals
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Blood Component Providers and Blood Centers
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Device Type:
Apheresis Devices
Leukapheresis Columns & Cell Separators
Leukoreduction Filters
Leukapheresis Disposables
By Application:
Research Applications
Therapeutic Applications
By End User:
Hospitals
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Blood Component Providers and Blood Centers
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Device Type:
Apheresis Devices
Leukapheresis Columns & Cell Separators
Leukoreduction Filters
Leukapheresis Disposables
By Application:
Research Applications
Therapeutic Applications
By End User:
Hospitals
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Blood Component Providers and Blood Centers
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Device Type:
Apheresis Devices
Leukapheresis Columns & Cell Separators
Leukoreduction Filters
Leukapheresis Disposables
By Application:
Research Applications
Therapeutic Applications
By End User:
Hospitals
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Blood Component Providers and Blood Centers
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Device Type:
Apheresis Devices
Leukapheresis Columns & Cell Separators
Leukoreduction Filters
Leukapheresis Disposables
By Application:
Research Applications
Therapeutic Applications
By End User:
Hospitals
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Blood Component Providers and Blood Centers
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Device Type:
Apheresis Devices
Leukapheresis Columns & Cell Separators
Leukoreduction Filters
Leukapheresis Disposables
By Application:
Research Applications
Therapeutic Applications
By End User:
Hospitals
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Blood Component Providers and Blood Centers
Company Profiles
Asahi Kasei Medical Co. Ltd.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Haemonetics Corporation
Terumo BCT Inc.
STEMCELL Technologies Inc.
Fresenius SE & Co. KGaA
BioIVT
Grifols, S.A
Key Biologics, LLC
“*” marked represents similar segmentation in other categories in the respective section.